Alto Neuroscience Inc.

ANRONYSE • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
23.69 USD
↘ 0.32 (1.33%)AT CLOSE (03:59 PM EDT)
23.86
↗ 0.17 (0.72%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
23.86
↗ 0.17 (0.72%)
🔴Market: CLOSED

Alto Neuroscience Inc. (ANRO) trades at $23.50 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place ANRO at a fair price relative to peers.

Technical & fundamental data as of Oct 6, 2026.

Open?$24.06
High?$24.70
Low?$23.50
Prev. Close?$24.01
Volume?576.6K
Avg. Volume?566.2K
VWAP?$23.91
Rel. Volume?1.02x
Bid / Ask
Bid?$18.40 × 1.0K
Ask?$29.32 × 100
Spread?$10.92
Midpoint?$23.86
Valuation & Ratios
Market Cap?929.6M
Shares Out?39.2M
Float?26.1M
Float %?74.3%
P/E Ratio?N/A
P/B Ratio?4.24
EPS?-$2.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
68
Market Cap
942.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.altoneuroscience.com
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
20
Piotroski F-Score?0/9Weak
Altman Z-Score?14.56Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.00%High
Short Interest?4.2M
Days to Cover?9.1
Free Float26.1M
Avg Daily Volume459.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?14.85Strong
Quick Ratio?14.85Strong
Cash Ratio?14.64Strong
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
42
4.24FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-38.4%WEAK▾
ROA?
S&P
3
-33.2%WEAK▾
Cash Flow & Enterprise
FCF?$-68841000
Enterprise Value?$704.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist